Mast cell chymase: morphofunctional characteristics

[1]  T. Biedermann,et al.  Mast cells as protectors of health. , 2019, The Journal of allergy and clinical immunology.

[2]  Xiaoying Zhou,et al.  Mast cell chymase impairs bronchial epithelium integrity by degrading cell junction molecules of epithelial cells , 2018, Allergy.

[3]  I. B. Bukhvalov,et al.  Mast cell proteases in specific tissular microenvironment formation: pathogenetic and diagnostical aspects , 2018, Therapy.

[4]  C. Ferrario,et al.  Critical role of the chymase/angiotensin-(1-12) axis in modulating cardiomyocyte contractility. , 2018, International journal of cardiology.

[5]  W. Robinson,et al.  Chemerin 156F, generated by chymase cleavage of prochemerin, is elevated in joint fluids of arthritis patients , 2018, Arthritis Research & Therapy.

[6]  M. Tiemann,et al.  Multiple immunolabeling with antibodies from the same host species in combination with tyramide signal amplification. , 2018, Acta histochemica.

[7]  M. Tiemann,et al.  Tryptase as a polyfunctional component of mast cells , 2018, Histochemistry and Cell Biology.

[8]  M. Tsai,et al.  Mast cells as sources of cytokines, chemokines, and growth factors , 2018, Immunological reviews.

[9]  F. Levi-Schaffer,et al.  Human eosinophils and mast cells: Birds of a feather flock together , 2018, Immunological reviews.

[10]  F. Redegeld,et al.  Non‐IgE mediated mast cell activation , 2018, Immunological reviews.

[11]  M. Tiemann,et al.  Identification of autofluorescent cells in human angioimmunoblastic T-cell lymphoma , 2017, Histochemistry and Cell Biology.

[12]  L. Dell’Italia,et al.  Multifunctional Role of Chymase in Acute and Chronic Tissue Injury and Remodeling. , 2018, Circulation research.

[13]  Guanbin Yang,et al.  Mast cell chymase promotes hypertrophic scar fibroblast proliferation and collagen synthesis by activating TGF-β1/Smads signaling pathway. , 2017, Experimental and therapeutic medicine.

[14]  W. Hardie,et al.  Mast cell chymase affects the proliferation and metastasis of lung carcinoma cells in vitro. , 2017, Oncology letters.

[15]  Krisztina V. Vukman,et al.  Mast cell secretome: Soluble and vesicular components. , 2017, Seminars in cell & developmental biology.

[16]  A. Zenclussen,et al.  Safeguarding of Fetal Growth by Mast Cells and Natural Killer Cells: Deficiency of One Is Counterbalanced by the Other , 2017, Front. Immunol..

[17]  F. Chan,et al.  The relationship between breast cancer molecular subtypes and mast cell populations in tumor microenvironment , 2017, Virchows Archiv.

[18]  M. Tiemann,et al.  Characterization of mast cell populations using different methods for their identification , 2017, Histochemistry and Cell Biology.

[19]  D. Guidolin,et al.  Spatial distribution of mast cells around vessels and glands in human gastric carcinoma , 2017, Clinical and Experimental Medicine.

[20]  B. Mulloy,et al.  Mast cell glycosaminoglycans , 2016, Glycoconjugate Journal.

[21]  Dhandeep Singh,et al.  Targeting mast cells: Uncovering prolific therapeutic role in myriad diseases. , 2016, International immunopharmacology.

[22]  A. Naukkarinen,et al.  Complement C3 is expressed by mast cells in cutaneous vasculitis and is degraded by chymase , 2016, Archives of Dermatological Research.

[23]  R. Graham,et al.  IGF-1 degradation by mouse mast cell protease 4 promotes cell death and adverse cardiac remodeling days after a myocardial infarction , 2016, Proceedings of the National Academy of Sciences.

[24]  M. Silverman,et al.  Biomarkers in Lung Diseases : From Pathogenesis to Prediction to New Therapies Mast cells and exosomes in hyperoxia-induced neonatal lung disease , 2016 .

[25]  I. Harvima,et al.  Mast cell chymase in experimentally induced psoriasis , 2016, The Journal of dermatology.

[26]  G. Caughey.  Mast cell proteases as pharmacological targets. , 2016, European journal of pharmacology.

[27]  G. Sammarco,et al.  Mast Cell-Targeted Strategies in Cancer Therapy , 2016, Transfusion Medicine and Hemotherapy.

[28]  E. Crivellato,et al.  The role of mast cell in tissue morphogenesis. Thymus, duodenum, and mammary gland as examples. , 2016, Experimental cell research.

[29]  C. Oliver,et al.  Mast Cell Proteases 6 and 7 Stimulate Angiogenesis by Inducing Endothelial Cells to Release Angiogenic Factors , 2015, PloS one.

[30]  L. Hellman,et al.  rMCP-2, the Major Rat Mucosal Mast Cell Protease, an Analysis of Its Extended Cleavage Specificity and Its Potential Role in Regulating Intestinal Permeability by the Cleavage of Cell Adhesion and Junction Proteins , 2015, PloS one.

[31]  B. Dahal,et al.  Chymase: a multifunctional player in pulmonary hypertension associated with lung fibrosis , 2015, European Respiratory Journal.

[32]  Hao Wang,et al.  RETRACTED: Differential expression of the angiotensin-(1-12)/chymase axis in human atrial tissue , 2015, Therapeutic advances in cardiovascular disease.

[33]  C. Oliver,et al.  The Role of Mast Cell Specific Chymases and Tryptases in Tumor Angiogenesis , 2015, BioMed research international.

[34]  P. Kovanen,et al.  Mast Cells as Effectors in Atherosclerosis , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[35]  J. Girard,et al.  Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells , 2014, Proceedings of the National Academy of Sciences.

[36]  M. Macías-Silva,et al.  Vesicular Trafficking and Signaling for Cytokine and Chemokine Secretion in Mast Cells , 2014, Front. Immunol..

[37]  C. Oliver,et al.  Mast Cell Function , 2014, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[38]  G. Pejler,et al.  Mast cell secretory granules: armed for battle , 2014, Nature Reviews Immunology.

[39]  N. Ehsan,et al.  Mast cells and angiogenesis in wound healing. , 2014, Analytical and quantitative cytopathology and histopathology.

[40]  B. Dahal,et al.  Mast cell chymase: an indispensable instrument in the pathological symphony of idiopathic pulmonary fibrosis? , 2013, Histology and histopathology.

[41]  G. Pejler,et al.  Mast cell chymase modulates IL-33 levels and controls allergic sensitization in dust-mite induced airway inflammation , 2012, Mucosal Immunology.

[42]  G. Shi,et al.  Mast cell chymase and tryptase as targets for cardiovascular and metabolic diseases. , 2012, Current pharmaceutical design.

[43]  Junjie Chen,et al.  Involvement of mast cell chymase in burn wound healing in hamsters , 2012, Experimental and therapeutic medicine.

[44]  A. Husain,et al.  Impact of Mast Cell Chymase on Renal Disease Progression. , 2012, Current hypertension reviews.

[45]  Susan M. Schlenner,et al.  Mast cell chymase reduces the toxicity of Gila monster venom, scorpion venom, and vasoactive intestinal polypeptide in mice. , 2011, The Journal of clinical investigation.

[46]  H. Collard,et al.  Lung mast cell density defines a subpopulation of patients with idiopathic pulmonary fibrosis , 2011, Histopathology.

[47]  G. Nilsson,et al.  Mast Cells as Sensors of Cell Injury through IL-33 Recognition , 2011, The Journal of Immunology.

[48]  G. Nilsson,et al.  Human Cord Blood-Derived Mast Cells Are Activated by the Nod1 Agonist M-TriDAP to Release Pro-Inflammatory Cytokines and Chemokines , 2010, Journal of Innate Immunity.

[49]  Gunnar Pejler,et al.  Mast cell proteases: multifaceted regulators of inflammatory disease. , 2010, Blood.

[50]  W. Böcker,et al.  Immunohistochemistry: Basics and Methods , 2010 .

[51]  A. Margulis,et al.  Mast Cell-Dependent Contraction of Human Airway Smooth Muscle Cell-Containing Collagen Gels: Influence of Cytokines, Matrix Metalloproteases, and Serine Proteases , 2009, The Journal of Immunology.

[52]  S. Knight,et al.  Novel insights into the biological function of mast cell carboxypeptidase A. , 2009, Trends in immunology.

[53]  M. Åbrink,et al.  Mast cell chymase contributes to the antibody response and the severity of autoimmune arthritis , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[54]  D. Groneberg,et al.  Increased mast cell number in human hypertensive nephropathy. , 2008, American journal of physiology. Renal physiology.

[55]  S. O. Kolset,et al.  Serglycin and secretion in human monocytes , 2008, Glycoconjugate Journal.

[56]  S. O. Kolset,et al.  Serglycin – Structure and biology , 2008, Cellular and Molecular Life Sciences.

[57]  S. Takai,et al.  Chymase activates promatrix metalloproteinase-9 in human abdominal aortic aneurysm. , 2008, Clinica chimica acta; international journal of clinical chemistry.

[58]  Y. Kitamura,et al.  Development of mast cells , 2007, Proceedings of the Japan Academy. Series B, Physical and biological sciences.

[59]  Annichkov Nm,et al.  [A. A. Maksimov: on the 100th anniversary of the unitarian theory of hematopoiesis]. , 2007 .

[60]  A. Chetta,et al.  Chymase-positive mast cells play a role in the vascular component of airway remodeling in asthma. , 2007, The Journal of allergy and clinical immunology.

[61]  G. Caughey.  Mast cell tryptases and chymases in inflammation and host defense , 2007, Immunological reviews.

[62]  H. Tsutsui,et al.  Human Mast Cell Chymase Cleaves Pro-IL-18 and Generates a Novel and Biologically Active IL-18 Fragment1 , 2006, The Journal of Immunology.

[63]  M. Åbrink,et al.  A role for serglycin proteoglycan in granular retention and processing of mast cell secretory granule components , 2006, The FEBS journal.

[64]  W. Frishman,et al.  Chymase: A New Pharmacologic Target in Cardiovascular Disease , 2006, Cardiology in review.

[65]  S. Takai,et al.  The relationship of tryptase- and chymase-positive mast cells to angiogenesis in stage I non-small cell lung cancer. , 2005, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[66]  M. Åbrink,et al.  A Key Role for Mast Cell Chymase in the Activation of Pro-matrix Metalloprotease-9 and Pro-matrix Metalloprotease-2* , 2005, Journal of Biological Chemistry.

[67]  N. Yawalkar,et al.  Mast cell chymase is increased in chronic atopic dermatitis but not in psoriasis , 2005, Archives of Dermatological Research.

[68]  M. Yacoub,et al.  Expression, localisation and function of ACE and chymase in normal and atherosclerotic human coronary arteries. , 2005, Vascular pharmacology.

[69]  R. Speth,et al.  Chymase-like angiotensin II-generating activity in end-stage human autosomal dominant polycystic kidney disease. , 2004, Journal of the American Society of Nephrology : JASN.

[70]  S. Takai,et al.  Significance of chymase inhibition for prevention of adhesion formation. , 2004, European journal of pharmacology.

[71]  S. Abe,et al.  Chymase-positive mast cells in small sized adenocarcinoma of the lung , 2003, Virchows Archiv.

[72]  P. Kovanen,et al.  Mast Cell Chymase Induces Smooth Muscle Cell Apoptosis by a Mechanism Involving Fibronectin Degradation and Disruption of Focal Adhesions , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[73]  T. Hirayama,et al.  Cutting Edge: VacA, a Vacuolating Cytotoxin of Helicobacter pylori, Directly Activates Mast Cells for Migration and Production of Proinflammatory Cytokines1 , 2002, The Journal of Immunology.

[74]  J. Keski‐Oja,et al.  Activation of paracrine TGF‐β1 signaling upon stimulation and degranulation of rat serosal mast cells: a novel function for chymase , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[75]  P. Kovanen,et al.  Chymase bound to heparin is resistant to its natural inhibitors and capable of proteolyzing high density lipoproteins in aortic intimal fluid. , 2001, Atherosclerosis.

[76]  K. Fang,et al.  Mast Cell Tissue Inhibitor of Metalloproteinase-1 Is Cleaved and Inactivated Extracellularly by α-Chymase1 , 2001, The Journal of Immunology.

[77]  P. Cui,et al.  Chymase is a potent chemoattractant for human monocytes and neutrophils , 2000, Journal of leukocyte biology.

[78]  I. Konstantinov.  In Search of Alexander A. Maximow: The Man Behind the Unitarian Theory of Hematopoiesis , 2000, Perspectives in biology and medicine.

[79]  R. Silver,et al.  Mast Cells Migrate from Blood to Brain , 2000, The Journal of Neuroscience.

[80]  G. Conner,et al.  Bronchial tissue kallikrein activity is regulated by hyaluronic acid binding. , 1999, American journal of respiratory cell and molecular biology.

[81]  A. Walls,et al.  Human mast cell chymase induces the accumulation of neutrophils, eosinophils and other inflammatory cells in vivo , 1998, British journal of pharmacology.

[82]  G. Angelini,et al.  Activation of matrix-degrading metalloproteinases by mast cell proteases in atherosclerotic plaques. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[83]  H. Okunishi,et al.  Skin mast cell promotion of matrix remodeling in burn wound healing in mice: relevance of chymase , 1998, Archives of Dermatological Research.

[84]  K. Fang,et al.  Dog Mast Cell α-Chymase Activates Progelatinase B by Cleaving the Phe88-Gln89 and Phe91-Glu92 Bonds of the Catalytic Domain* , 1997, The Journal of Biological Chemistry.

[85]  S. Oparil,et al.  Angiotensin II formation from ACE and chymase in human and animal hearts: methods and species considerations. , 1997, American journal of physiology. Heart and circulatory physiology.

[86]  R. Diegelmann,et al.  Cleavage of Type I Procollagen by Human Mast Cell Chymase Initiates Collagen Fibril Formation and Generates a Unique Carboxyl-terminal Propeptide* , 1997, The Journal of Biological Chemistry.

[87]  P. Kovanen.  Chymase-containing mast cells in human arterial intima: implications for atherosclerotic disease. , 1997, Heart and vessels.

[88]  M. Welle.  Development, significance, and heterogeneity of mast cells with particular regard to the mast cell‐specific proteases chymase and tryptase , 1997, Journal of leukocyte biology.

[89]  L. Audigé,et al.  The Equine Endometrial Mast Cell during the Puerperal Period: Evaluation of Mast Cell Numbers and Types in Comparison to Other Inflammatory Changes , 1997, Veterinary pathology.

[90]  S. Lazarus,et al.  Dog mastocytoma cells secrete a 92-kD gelatinase activated extracellularly by mast cell chymase. , 1996, The Journal of clinical investigation.

[91]  J. Taipale,et al.  Human Mast Cell Chymase and Leukocyte Elastase Release Latent Transforming Growth Factor-β1 from the Extracellular Matrix of Cultured Human Epithelial and Endothelial Cells (*) , 1995, The Journal of Biological Chemistry.

[92]  P. Kovanen,et al.  Activation of human interstitial procollagenase through direct cleavage of the Leu83-Thr84 bond by mast cell chymase. , 1994, The Journal of biological chemistry.

[93]  D. Ganten,et al.  Cardiac angiotensin II formation: the angiotensin-I converting enzyme and human chymase. , 1993, European heart journal.

[94]  K. Misono,et al.  Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. , 1990, The Journal of biological chemistry.

[95]  L. Schwartz,et al.  Tryptase, a mediator of human mast cells. , 1990, The Journal of allergy and clinical immunology.

[96]  J. Nadel,et al.  Mast cell chymase potentiates histamine-induced wheal formation in the skin of ragweed-allergic dogs. , 1990, The Journal of clinical investigation.

[97]  L. Schwartz,et al.  Mast cell heterogeneity , 1989, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[98]  D. M. Dvorak.  Human Mast Cells , 1989, Advances in Anatomy Embryology and Cell Biology.

[99]  B. Zweiman,et al.  Release of tryptase together with histamine during the immediate cutaneous response to allergen. , 1987, The Journal of allergy and clinical immunology.

[100]  L. Schwartz,et al.  The major enzymes of human mast cell secretory granules. , 1987, The American review of respiratory disease.

[101]  L. Schwartz,et al.  Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells. , 1987, Journal of immunology.

[102]  Schwartz Lb,et al.  Mediators of human mast cells and human mast cell subsets. , 1987 .

[103]  K. Barrett,et al.  Mast cell numbers and histamine levels in synovial fluids from patients with diverse arthritides. , 1986, Arthritis and rheumatism.

[104]  D. Seldin,et al.  Purification and characterization of protease-resistant secretory granule proteoglycans containing chondroitin sulfate di-B and heparin-like glycosaminoglycans from rat basophilic leukemia cells. , 1985, The Journal of biological chemistry.

[105]  D. Seldin,et al.  Homology of the rat basophilic leukemia cell and the rat mucosal mast cell. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[106]  J. Denburg,et al.  Mast cell heterogeneity: derivation and function, with emphasis on the intestine. , 1982, The Journal of allergy and clinical immunology.

[107]  J. Gauldie,et al.  Mucosal mast cells. I. Isolation and functional characteristics of rat intestinal mast cells. , 1982, Journal of immunology.

[108]  H. Seppä,et al.  Susceptibility of soluble and matrix fibronectins to degradation by tissue proteinases, mast cell chymase and cathepsin G. , 1981, The Journal of biological chemistry.

[109]  M. Hughes,et al.  Mast cells in human health and disease. , 2015, Methods in molecular biology.

[110]  E. Crivellato,et al.  The phylogenetic profile of mast cells. , 2015, Methods in molecular biology.

[111]  M. Tsai,et al.  Approaches for analyzing the roles of mast cells and their proteases in vivo. , 2015, Advances in immunology.

[112]  M. Tiemann,et al.  The contribution of Paul Ehrlich to histochemistry: a tribute on the occasion of the centenary of his death , 2014, Virchows Archiv.

[113]  K. Alysandratos,et al.  Mast cells and inflammation. , 2012, Biochimica et biophysica acta.

[114]  G. Pejler,et al.  Serglycin: the master of the mast cell. , 2012, Methods in molecular biology.

[115]  G. Caughey.  Mast cell proteases as protective and inflammatory mediators. , 2011, Advances in experimental medicine and biology.

[116]  M. Tsai,et al.  Mast cells: versatile regulators of inflammation, tissue remodeling, host defense and homeostasis. , 2008, Journal of dermatological science.

[117]  M. Buckley,et al.  Identification of mast cells and mast cell subpopulations. , 2008, Methods in molecular medicine.

[118]  M. Åbrink,et al.  Mast cell proteases. , 2007, Advances in immunology.

[119]  H. Urata.  Chymase and Matrix Metalloproteinase , 2007, Hypertension Research.

[120]  N. M. Annichkov,et al.  [A. A. Maksimov: on the 100th anniversary of the unitarian theory of hematopoiesis]. , 2007, Arkhiv patologii.

[121]  G. Youngberg,et al.  Mast cell ultrastructure and staining in tissue. , 2006, Methods in molecular biology.

[122]  S. Takai,et al.  Expression of chymase‐positive cells in gastric cancer and its correlation with the angiogenesis , 2006, Journal of surgical oncology.

[123]  E. Crivellato,et al.  The mast cell: an active participant or an innocent bystander? , 2004, Histology and histopathology.

[124]  J. Bienenstock,et al.  Mast cells , 2004, Springer Seminars in Immunopathology.

[125]  V. L. Bykov.  [The development and heterogeneity of mast cells]. , 2000, Morfologiia.

[126]  D. Metcalfe,et al.  Mast cells. , 1997, Physiological reviews.

[127]  Kovanen Pt.  Chymase-containing mast cells in human arterial intima: implications for atherosclerotic disease. , 1997 .

[128]  S. Galli,et al.  New insights into "the riddle of the mast cells": microenvironmental regulation of mast cell development and phenotypic heterogeneity. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[129]  Y. Kitamura,et al.  Heterogeneity of mast cells and phenotypic change between subpopulations. , 1989, Annual review of immunology.

[130]  L. Schwartz,et al.  Mediators of human mast cells and human mast cell subsets. , 1987, Annals of allergy.